Latest Gadolinium Stories
[286 Pages Report] Contrast Media/Agents Market reports is a comprehensive review specifically for contrast media used in medical and radiological procedures comprising of market analysis by product,
“Contrast Media/Contrast Agents Market By Product (Iodinated, Gadolinium & Barium), By Technique (X-ray, CT, MRI, Cath Lab & Ultrasound) & By Application (Radiology, Interventional
The national class action lawyers at Glen Lerner Injury Attorneys announced that they are now reviewing potential gadolinium contrast claims for people with impaired kidneys who underwent a magnetic
Researchers at Harvard-affiliated McLean Hospital have shown a new category of "green" nanoparticles comprised of a non-toxic, protein-based nanotechnology that can non-invasively cross the blood brain barrier and is capable of transporting various types of drugs.
CAGE Chemicals, University of Turin and Aspect Imaging to Develop Applications and Products for Molecular Imaging on Aspect's M2(TM) Compact MRI System for Preclinical Imaging TORONTO, Canada, SHOHAM, Israel, and TURIN, Italy, June 29, 2011 /PRNewswire/ - Aspect Imaging today announced its agreement with CAGE Chemicals to develop and manufacture Aspect's PhenoQuant(TM) line of contrast agents for preclinical research.
A simple blood test may help prevent a serious complication associated with a contrast agent commonly used in MRI exams.
A recent study shows how one medical center implemented strict protocols for administering gadolinium-based contrast agents (GBCAs) before imaging and eliminated new cases for nephrogenic system fibrosis (NSF).